Zoetis
Bovi-Shield GOLD FP 5 VL5
Bovi-Shield GOLD FP 5 VL5
Couldn't load pickup availability
This vaccine may be administered to pregnant cows, or calves nursing pregnant cows, provided cows were vaccinated, according to label directions, with any Bovi-Shield GOLD FP vaccine within the past 12 months. Failure to follow these directions can result in abortion. Protects against fetal infection caused by (BVD) Types 1 and 2 viruses. Bovi-Shield GOLD FP 5 VL5 contains a modified live virus (MLV) and requires reconstitution with the included liquid bacterin (Vibrio/Leptoferm-5) prior to administration. It should be administered intramuscularly in the neck region. Do not administer within 21 days before slaughter. Do not vaccinate calves under 3 months of age. Annual revaccination is recommended.
The freeze-dried vaccine is a preparation of modified live virus (MLV) strains of IBR, BVD (Types 1 and 2), PI3 and BRSV. The Campylobacter bacterin is an inactivated suspension of C. fetus. It is combined with inactivated Leptospira bacterin prepared from whole cultures of the agents indicated. The Campylobacter-Leptospira bacterin is supplied as a diluent for the IBR-BVD-PI3-BRSV vaccine.
Bovi-Shield GOLD FP 5 VL5 is for the vaccination of healthy beef and dairy cows and heifers prior to breeding as an aid in the prevention of the following diseases of cattle:
Respiratory diseases:
1. Infectious bovine rhinotracheitis (IBR)
2. Bovine viral diarrhea (BVD Types 1 and 2)
3. Bovine viral diarrhea (BVD Type 2 testicular infection)
4. Parainfluenza3 (PI3)
5. Bovine respiratory syncytial virus (BRSV)
Leptospirosis caused by:
1. Leptospira canicola
2. L. grippotyphosa
3. L. hardjo
4. L. icterohaemorrhagiae
5. L. pomona
Dosage
2 mL dose to all breeding cows and heifers one month prior to breeding or being added to the herd, followed by single doses of Vibrio/Leptoferm 5 and Bovi-shield BRSV 3-4 weeks later. Annual revaccination is recommended. May be administered to pregnant cattle and calves nursing pregnant cows as they were vaccinated according to label directions. Not for calves under 3 months of age. 21 day slaughter withhold.
Indications
Prevents persistently infected calves caused by BVD Types 1 and 2 viruses; aids in preventing abortion caused by IBR virus; respiratory disease caused by IBR virus, BVD Types 1 and 2 viruses, parainfluenza 3 (PI3) virus and bovine respiratory syncytial virus (BRSV); BVD Type 2 testicular infection; campylobacteriosis (vibriosis) caused by Campylobacter fetus (vibrio) and leptospirosis caused by the five Leptospira serovars indicated above.
IMPORTANT SAFETY INFORMATION
Do not use in pregnant cattle (abortions can result) unless they were vaccinated, according to label directions, with any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP vaccine prebreeding initially and within 12 months thereafter. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above. To help ensure safety in pregnant cattle, heifers must receive at least 2 doses of any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP vaccine with the second dose administered at least 30 days prebreeding.
Manufacturer and/or Label Information
Manufacturer and/or Label Information
www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website:TETANUS TOXOID-CONCENTRATED
Colorado Serum
Adjuvanted
GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
Safety in pregnant animals is unknown.
Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.
Each serial is tested for purity, safety, and potency in accordance with USDA requirements.
Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.
Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.
Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.
DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.
PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.
DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.
Horses: 1 ml IM
Cattle: 1 ml SC or IM
Sheep, Goats, Swine: 0.5 ml SC or IM
Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.
OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.
THE PEAK OF QUALITY SINCE 1923
VLN: 188 / PCN: 8601.00
COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216
303-295-752
www.colorado-serum.com
Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.
FOR VETERINARY USE ONLY
Order #
10 - 1 ml vials
10 - 1 dose vials
11411
10 ml
10 doses
11415
CPN: 1101033.3
Dimensions
Dimensions
Care information
Care information
Let customers speak for us

